Dose-Response to Resistance Exercise on Cardiovascular Health (DoReps)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Duck-chul Lee, PhD
- Phone Number: 412-383-4004
- Email: dclee@pitt.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15219
- Recruiting
- Physical Activity Research Center (PARC)
-
Contact:
- Duck-chul Lee, PhD
- Phone Number: 412-383-4004
- Email: dclee@pitt.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Non-Smoker
- Overweight or Obese: Body Mass Index 25-43 kg/m2
- Inactive: not meeting the US resistance and aerobic exercise guidelines over the last 6 months
- Walking <7,000 steps/day at baseline
- Capable of performing the required exercise training
Exclusion Criteria:
Absolute
- Unstable coronary heart disease or heart failure
- Uncontrolled arrhythmias or severe aortic stenosis
- Acute myocarditis, endocarditis, or pericarditis
- Cancer, requiring treatment in the past 5 years
- Autoimmune diseases, affecting immune system
- Plans to be away ≥4 weeks in the next 1 year
- Pregnancy/anticipated pregnancy during the study
- Other medical condition that is life-threatening or can interfere with or be aggravated by the exercise training
- Uncontrolled Diabetes (HbA1c ≥8.0),
- Hypertensive Blood Pressure ≥160 mm Hg Systolic and/or 100 mm Hg Diastolic,
Relative (should consult a physician)
- Major risk factors for coronary heart disease
- Uncontrolled diabetes or musculoskeletal limitations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Aerobic Exercise (AE) only
Aerobic exercise (AE) training will consist of 60 min of treadmill, elliptical, or bike exercise at a moderate to vigorous (50-80% of heart rate reserve).
Intensity of the exercise sessions will be built of gradually.
Sessions will occur 2 times per week for the duration of the year.
|
Aerobic exercise training will consist of 60 min of treadmill, elliptical, or bike exercise at a moderate to vigorous (50-80% of heart rate reserve).
Intensity of the exercise sessions will be built of gradually.
Sessions will occur 2 times per week for the duration of the year trial
Other Names:
|
|
Experimental: 30 min of resistance exercise (RE)
30 min of resistance exercise (RE) will consist of 30 total minutes of resistance exercise each week (15 min each session) in addition to 60 min of aerobic exercise (AE) each week (30 min each session).
Each 15 min session of RE will consist of 2 sets of 8-15 repetitions at 50-80% of 1-rep max of 4 exercises.
AE will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 45 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
|
30 min of resistance exercise (RE) will consist of 30 total minutes of resistance exercise each week (15 min each session) in addition to 60 min of aerobic exercise each week (30 min each session).
Each 15 min session of resistance exercise will consist of 2 sets of 8-15 repetitions at 50-80% of 1-rep max of 4 exercises.
Aerobic exercise will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 45 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
Other Names:
|
|
Experimental: 60 min of resistance exercise (RE)
60 min of resistance exercise (RE) will consist of 60 total minutes of resistance exercise each week (30 min each session) in addition to 60 min of aerobic exercise each week (30 min each session).
Each 30 min session of resistance exercise will consist of 2 sets of 8-15 repetitions at 50-80% of 1-rep max of 8 exercises.
Aerobic exercise will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 60 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
|
60 min of resistance exercise (RE) will consist of 60 total minutes of resistance exercise each week (30 min each session) in addition to 60 min of aerobic exercise each week (30 min each session).
Each 30 min session of resistance exercise will consist of 2 sets of 8-15 repetitions at 50-80% of 1-rep max of 8 exercises.
Aerobic exercise will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 60 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
Other Names:
|
|
Experimental: 120 min of resistance exercise (RE)
120 min of resistance exercise (RE) will consist of 120 total minutes of resistance exercise each week (60 min each session) in addition to 60 min of aerobic exercise each week (30 min each session).
Each 60 min session of resistance exercise will consist of 3 sets of 8-15 repetitions at 50-80% of 1-rep max of 10 exercises.
Aerobic exercise will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 90 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
|
120 min of resistance exercise (RE) will consist of 120 total minutes of resistance exercise each week (60 min each session) in addition to 60 min of aerobic exercise each week (30 min each session).
Each 60 min session of resistance exercise will consist of 3 sets of 8-15 repetitions at 50-80% of 1-rep max of 10 exercises.
Aerobic exercise will consist of treadmill, elliptical, or bike exercise at moderate to vigorous intensity (50-80% of heart rate reserve).
Intensity of the exercise sessions will be increased gradually.
With 1 min rest between sets, this plan is estimated to take approximately 90 min per session.
Sessions will occur 2 times per week for the duration of 1 year.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in composite cardiovascular risk score at 6 months
Time Frame: Baseline and 6 months
|
The primary outcome will be change from baseline to 6 months in the average composite cardiovascular disease (CVD) risk z-score comprising systolic Blood pressure (SBP), Low-Density lipoprotein cholesterol (LDL-C), fasting glucose, and percent body fat; lower scores indicate better overall CVD risk profile.
Each CVD risk factor at baseline and 6 months will be individually standardized to sex-specific z -scores with a mean of 0 and standard deviation (SD) of 1 based on the formula (observed value-mean)/SD for each participant, using the baseline means and SDs from the entire sample.
|
Baseline and 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in arterial stiffness at 6 months
Time Frame: Baseline and 6 months
|
Primary outcome will assess changes in all 4 groups from baseline to 6 months on aortic arterial stiffness (purse wave velocity).
|
Baseline and 6 months
|
|
Change from baseline in inflammatory markers at 6 months
Time Frame: Baseline and 6 months
|
Outcome will assess changes in all 4 groups from baseline to 6 months inflammatory markers (e.g., C-reactive protein, Interleukin 6, Tumor Necrosis Factor alpha).
|
Baseline and 6 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to resistance exercise associated with dose prescription at 12 months
Time Frame: 6 months and 12 months
|
This secondary outcome seeks to assess the resistance exercise dose associated with the best adherence to the resistance exercise training prescription during the self-maintenance period of months 6 to 12.
|
6 months and 12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Duck-chul Lee, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavior
- Motor Activity
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Therapeutics
- Physical Therapy Modalities
- Patient Care
- Exercise Therapy
- Rehabilitation
- Aftercare
- Continuity of Patient Care
- Physical Conditioning, Human
- Exercise
- Resistance Training
Other Study ID Numbers
Other Study ID Numbers
- STUDY24070155
- R01HL171098 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.